Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...

Imagine trying to design a key for a lock that is constantly changing its shape. That is the exact challenge we face in ...

Simplify complex concepts with electric field problems made easy using Python and vectors! ⚡ In this video, we demonstrate step-by-step how to calculate electric fields, visualize vector directions, ...

IITs now offer various programs that do not require JEE scores, such as executive robotics (IIT Delhi), genetic engineering (IIT Guwahati), engineering mathematics (IIT Kharagpur), thermodynamics (IIT ...

These institutes now offer short-term and certificate courses in advanced fields like data science, artificial intelligence, ...

Beyond JEE, IITs are opening doors with online and executive courses in high-demand fields like AI, robotics, biotechnology, and programming. These programmes include Engineering Mathematics, Genetic ...

From data science and artificial intelligence to machine learning, robotics, virtual and augmented reality, and UX strategy, IITs equip learners with industry-ready skills and bypass the traditional ...

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease candidate it had once hoped would become a best-in-class treatment. The oral ...

NEW YORK CITY (WABC) -- New York City is launching a groundbreaking program to prevent sudden deaths. The city's medical examiner will offer free genetic screening to at-risk family members of people ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Chicago philanthropists Don and Anne Edwards have donated ...

The South Florida Water Management District's Python Elimination Program announced its October winners. Hunter Donna Kalil captured the most pythons in October with 21, earning her a bonus award.

After its cannabidiol gel candidate failed a phase 3 trial in fragile X syndrome, Harmony Biosciences has now paused development of the asset in a different genetic disease. Harmony announced in ...